|
|
| 2021, Vol. 30(1): 66-70 DOI: 10.3760/cma.j.cn113030-20200324-00131 | ||
| Efficacy of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) therapy in the primary prevention of concurrent chemoradiotherapy-induced neutropenia | ||
| Chen Yang, Wang Wei, Zhang Ruiping, Liu Ransheng, Zhang Aixu, Wang Zhizhen | ||
| Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer;Key Laboratory of Cancer Prevention and Therapy of Tianjin;Tianjin's Clinical Research Center for Cancer;Tianjin 300060, China | ||
| Received 2020-03-24 Revised null | ||
| Supporting info | ||
| null | ||
|
